HCA vs NAGE · P/E 17, rev $75.60B vs P/E 59, rev $61.3M
HCA Holdings Inc (HCA) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the HCA and NAGE stock pages for the full models.
Not investment advice.